Reports Outline Asthma Research from University of Ioannina (Capturing patient-centered outcomes using innovative technologies in adults with severe eosinophilic asthma on benralizumab: The EMPOWAIR real-world study design).

Předmět:	TECHNOLOGICAL innovations ASTHMA BRONCHIAL diseases RESPIRATORY diseases OBSTRUCTIVE lung diseases
Zdroj:	Immunotherapy Weekly; 9/25/2023, p1452-1452, 1p
Abstrakt:	Keywords: Asthma; Benralizumab Therapy; Blood Cells; Bronchial Diseases and Conditions; Drugs and Therapies; Eosinophils; Granulocytes; Health and Medicine; Hemic and Immune Systems; Immune System Diseases and Conditions; Immunology; Immunotherapy; Lung Diseases and Conditions; Monoclonal Antibodies; Obstructive Lung Diseases and Conditions; Pharmaceuticals; Respiratory Hypersensitivity; Respiratory Tract Diseases and Conditions; Technology EN Asthma Benralizumab Therapy Blood Cells Bronchial Diseases and Conditions Drugs and Therapies Eosinophils Granulocytes Health and Medicine Hemic and Immune Systems Immune System Diseases and Conditions Immunology Immunotherapy Lung Diseases and Conditions Monoclonal Antibodies Obstructive Lung Diseases and Conditions Pharmaceuticals Respiratory Hypersensitivity Respiratory Tract Diseases and Conditions Technology 1452 1452 1 09/25/23 20230925 NES 230925 2023 SEP 29 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A new study on asthma is now available. Asthma, Benralizumab Therapy, Blood Cells, Bronchial Diseases and Conditions, Drugs and Therapies, Eosinophils, Granulocytes, Health and Medicine, Hemic and Immune Systems, Immune System Diseases and Conditions, Immunology, Immunotherapy, Lung Diseases and Conditions, Monoclonal Antibodies, Obstructive Lung Diseases and Conditions, Pharmaceuticals, Respiratory Hypersensitivity, Respiratory Tract Diseases and Conditions, Technology. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu